Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

1885studies indexed841with human data111registered trials1630carry a numeric findingLibrarian added 0 studies today
Showing 13 studiesSortNewest indexed
B
grade
Long-term mortality and risk of chronic kidney disease in children following severe malaria complicated by acute kidney injury: a prospective observational study.
Semax · The Lancet. Global health · 2026 · Observational · n=1077Top journal
Children with AKI following severe malaria face increased long-term mortality, underscoring the need for improved post-acute care strategies in malaria-endemic areas.
Adjusted hazard ratio for mortality risk was 3.36 (95% CI 2.22-5.10) for AKI survivors.
A
grade
8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.
Semax · The Lancet. Global health · 2026 · RCT · Phase 3 · n=14850Top journal
A single dose of Vi-TT vaccine offers strong protection against typhoid fever in Nepali children for up to 4 years, with effectiveness decreasing by 8 years.
Vaccine effectiveness was 77% (95% CI 46-90; p=0.0006) in the 2020-21 Vi-TT cohort.
B
grade
Prevalence of vision and hearing impairment in Australia: a nationally representative survey of Indigenous and non-Indigenous Australians aged 50 years and older.
Semax · The Lancet. Global health · 2026 · Observational · n=4519Top journal
The study found that vision impairment is significantly more prevalent among Indigenous Australians compared to non-Indigenous Australians, highlighting a critical health disparity.
Age-standardised prevalence of any vision impairment was 11·1% (95% CI 8·4-14·5) among Indigenous participants.
Showing 13 of 13